LQDA: Nilai perusahaan marang bathi resik Liquidia Technologies

Lambang korporat lan logo Liquidia Corp (LQDA)

The price-to-earnings trend for Liquidia Corporation (LQDA) reflects expectations regarding the commercialization of Yutrepia for the treatment of pulmonary hypertension. The value of -54.30 captures the magnitude of this parameter. Business development relies on U.S. drug delivery centers. Asset stability is ensured by patent protection for inhalation methods, creating significant potential for profit growth driven by the ease of drug administration.

LQDA Liquidia Inc.: Koefisien rega marang bathi ing interval 04.07.2022 - 15.11.2026

Rincian metrik komprehensif lan analitis Liquidia Corp (LQDA)

- rega lan prakiraan konsensus rega:
Rega saham Liquidia Technologies|LQDA - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Liquidia Technologies|LQDA - Nilai Total Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Aset Bersih saben Saham Liquidia|LQDA - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku liquidia.com|LQDA - Total Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Rasio Kabeh Utang marang Dana Pribadi Liquidia Corporation|LQDA - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal liquidia.com|LQDA - Utang perusahaan|Rasio utang marang aset resik Liquidia Technologies|LQDA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Liquidia|Koefisien jangkoan perantara liquidia.com
- data bathi bisnis lan rasio investasi:
LQDA - Bathi resik perusahaan|Proyeksi bathi resik Liquidia Corporation|LQDA - Koefisien rega marang bathi|Pangali Forward P/E Liquidia Technologies|LQDA - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Liquidia Corp|LQDA - Bathi operasional EBITDA|Bathi saben saham sajrone 12 wulan pungkasan Liquidia|LQDA - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan liquidia.com|LQDA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Liquidia Corporation
- rincian pendapatan lan dodolan emiten:
LQDA - Dodolan perusahaan|Pendapatan mangsa ngarep perusahaan Liquidia|LQDA - Multiplikator P/S|Multiplikator forward rega marang pendapatan Liquidia Technologies|LQDA - Wutah dodolan YoY sajrone rolas wulan kepungkur
Analisis komprehensif perusahaan:Liquidia Corp - LQDA
Barang unggulan Liquidia

The P/E ratio reflects the market value of a single unit of net profit, allowing an investor to determine the extent of an asset's overvaluation or its potential undervaluation. Analyzing the estimated P/E of Liquidia Corporation (LQDA) helps align current market expectations with the lengthy certification timelines for proprietary drugs, where the risk of clinical trial failure directly impacts the fair valuation multiple of the business.

Analisis perusahaan pesaing

HLN: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalisasi marang bathi|AMRX: Koefisien rega marang bathi|Perrigo - Rasio rega pasar marang bathi resik|ALVO: Pangali P/E|Galapagos Genomics - Nilai perusahaan marang bathi resik|ANIP (ANI Pharmaceuticals Inc) - Pangali P/E|Kapitalisasi marang bathi mannkindcorp.com MNKD|Rasio rega marang bathi Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Nilai perusahaan marang bathi resik|Pangali P/E SPRY (ARS Pharmaceuticals Inc)|Rasio rega pasar marang bathi resik TBPH (Theravance)|AQST - Rasio rega marang bathi|scPharmaceuticals (SCPH) - Koefisien rega marang bathi|TECX: Pangali P/E|Pangali rega marang bathi TNXP|Rasio rega marang bathi China SXT Pharmaceuticals, Inc.|EPRX: Nilai perusahaan marang bathi resik|Pangali P/E BHST|EXOZ - Kapitalisasi marang bathi|Pangali P/E ORMP (oramed.com)|Pangali P/E enterabio.com ENTX|HYFT - Rasio rega marang bathi|Periode bali modal bisnis ABVC BioPharma, Inc ABVC|CPIX: Pangali P/E|Quantum BioPharma Ltd - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi FGEN|Telomir Pharmaceuticals, Inc. - Kapitalisasi marang bathi resik|Pangali P/E RANI|SNYR (Synergy CHC) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Rallybio RLYB|Lexaria Bioscience (LEXX) - Kapitalisasi marang bathi|PULM - Rasio rega marang bathi|Periode bali modal bisnis Pheton Holdings PTHL|APM (Aptorum) - Koefisien rega marang bathi|Lyra Therapeutics, Inc. (LYRA) - Pangali P/E|IBO (impactbiomedinc.com) - Pangali P/E|TNFA (TNF Pharmaceuticals) - Rasio rega pasar marang bathi resik|Rasio rega marang bathi cbdmd.com (YCBD)|Periode bali modal bisnis PainReform Ltd|Pangali P/E CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalisasi marang bathi|OPTN - Rasio rega marang bathi|Pieris Pharmaceuticals - Rasio rega pasar marang bathi resik|PROC (Procaps Group) - Koefisien rega marang bathi|PTPI - Periode bali modal bisnis|Rasio rega marang bathi Qilian International Holding Group Limited|SLRN: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi TFFP (TFF Pharma)